The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)
NCT03851887 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2019-02-22
Summary
To evaluate the efiicacy of TAI combine SBRT in unresectable HCC
Conditions
Interventions
- COMBINATION_PRODUCT
-
TAI combine SBRT
TAI combine SBRT
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2020-01-31
- Completion
- 2022-01-31
Countries
- China
Study Locations
More Related Trials
-
SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)
NCT05718232 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC
NCT03116984 ·Status: UNKNOWN ·Phase: PHASE3
-
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
NCT03368651 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma
NCT06867432 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Bioinformation Therapy for Liver Cancer
NCT03239158 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife
NCT02363218 ·Status: UNKNOWN ·Phase: PHASE2
-
Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma
NCT03609151 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE
NCT04161287 ·Status: UNKNOWN
-
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma
NCT05609695 ·Status: UNKNOWN
-
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
NCT04387695 ·Status: UNKNOWN ·Phase: PHASE3
-
SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma.
NCT06739317 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
NCT01328223 ·Status: UNKNOWN
-
Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
NCT01020812 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
SIRT for Potentially Resectable HCC
NCT05994859 ·Status: RECRUITING ·Phase: NA
-
Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy
NCT05057104 ·Status: UNKNOWN
-
RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma
NCT02964260 ·Status: UNKNOWN ·Phase: NA
-
Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)
NCT07293468 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC
NCT05596630 ·Status: RECRUITING ·Phase: NA
-
Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy
NCT05811481 ·Status: RECRUITING
-
Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma
NCT01833299 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Sequential RT After Triple Therapy for uHCC
NCT07052448 ·Status: ENROLLING_BY_INVITATION
-
A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma
NCT07070076 ·Status: RECRUITING ·Phase: NA
-
Thermal Ablation Followed by Immunotherapy for HCC
NCT03864211 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC
NCT06639971 ·Status: NOT_YET_RECRUITING
-
Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT
NCT06408753 ·Status: COMPLETED